Boardroom Alpha
Boardroom Alpha
LFWD · Current Report (Form 8-K) · Filed February 27, 2026

Lifeward Ltd — Current Report (Form 8-K)

Form
8-K
Filed
February 27, 2026
Period
Feb 24, 2026
Ticker
LFWD
Accession
0001178913-26-000654
Boardroom Alpha · Filing insights

Lifeward Ltd.'s Class I director Hadar Levy steps down effective Feb 24, 2026. No disagreement.

About Lifeward Ltd
Market cap
$22M
1Y TSR
−45.0%
3Y TSR
−48.2%
Board grade
C-
Sector
Healthcare
CEO
Mark Grant
Last annual meeting: Jan 6, 2026 · View full Lifeward Ltd profile →


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of Report (Date of earliest event reported): February 24, 2026
 
Lifeward Ltd.

(Exact Name of Registrant as Specified in its Charter)
  
Israel
 
001-36612
 
Not Applicable
(State or Other Jurisdiction of Incorporation)
 
(Commission File Number)
 
(IRS Employer Identification No.)

2 Cabot Rd., Hudson, MA
 
01749
(Address of principal executive offices)
 
(Zip Code)
 
Registrant’s telephone number, including area code: +508.251.1154

Not applicable
(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class
 
Trading Symbol
 
Name of each exchange on which registered
Ordinary Shares, no par value
 
LFWD
 
Nasdaq Capital Market

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 


Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On February 24, 2026, Hadar Levy, current Class I director of the Board of Directors (the “Board”) of Lifeward Ltd. (the “Company”) notified the Board of his decision to step down from the Board, effective as of February 24, 2026. The departure of Mr. Levy did not result from any disagreement with the Company on any matter relating to its operations, policies or practices.  The Company extends its deepest gratitude to Mr. Levy for his distinguished service to the Board and lasting contributions to the Company.


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Lifeward Ltd.
 
 
 
Dated: February 27, 2026
By:
/s/ Almog Adar
 
Name:
Almog Adar
 
Title:
Chief Financial Officer
 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Lifeward Ltd (LFWD)

Reference

Frequently asked questions

When did Lifeward Ltd file this 8-K?
Lifeward Ltd (LFWD) filed this Current Report (Form 8-K) with the SEC on February 27, 2026. The accession number assigned by EDGAR is 0001178913-26-000654.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Lifeward Ltd.'s Class I director Hadar Levy steps down effective Feb 24, 2026. No disagreement. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Lifeward Ltd's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Lifeward Ltd has filed under CIK 1607962, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer